DRAPER, UT--(Marketwired - Jun 30, 2014) - Nutranomics (OTCBB: NNRX), U.S. manufacturer of high quality, whole food based vitamins and supplements designed to support people aiming for a healthy lifestyle and aid those suffering from various diseases, has recorded an increase in wholesale and retail sales in its first three quarters as a public company. From the first fiscal quarter to the second, wholesale and retail sales increased by 7% and from the second to the third, wholesale and retail sales increased by 18%. Overall, wholesale and retail sales increased 27% from the first through the third quarters.
General Manager, Michael Brousseau, attributes that sales increase to public demand for higher quality supplements, "Consumers are trying harder than ever before to make healthy choices for their families. Nutranomics provides a best in class product line of whole food, child-safe supplements for families."
To learn more about Nutranomics supplements, visit http://www.nutranomics.com
Nutranomics has been at the forefront of research and development of nutritional food products since its inception in 1995. At present, we are one of the leading brands in the manufacture of safe, high quality vitamins and supplements distributed in various countries around the world. More than just a health supplement manufacturer, we also see our role in supporting the worldwide community of people aiming for a healthy lifestyle.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements," which include statements that are not purely historical or are regarding beliefs, plans, expectations or intentions. Actual results could differ from those in any forward-looking statements due to numerous factors, including the uncertainties associated with developing and marketing new products, operating as a development stage company, competition, and market conditions. These forward-looking statements are made as of the date hereof, and we assume no obligation to update the statements except as required by law. Although we believe that any beliefs, plans, expectations or intentions contained herein are reasonable, there can be no assurance that they will prove to be accurate. Investors should refer to the information and risk factor disclosure in our reports filed with the SEC, available at www.sec.gov.
These statements have not been evaluated by the Food and Drug Administration. The company's products are not intended to diagnose, treat, cure or prevent any disease.